Table 5 Estimated growth rates for human xenografts of different cancer types in mice reported in the literature
From: Model-based assessment of combination therapies – ranking of radiosensitizing agents in oncology
\({k}_{net}\)[1/day] | \({k}_{g}\)[1/day] | \({k}_{k}\)[1/day] | Paper | Cancer Type |
|---|---|---|---|---|
0.127 | 0.127 | - | Koch et al. [27] | Colorectal |
0.144 | 0.144 | - | Goteti et al. [32] | Colorectal |
0.27 | 0.27 | - | Simeoni et al. [31] | Colorectal |
0.166 | 0.166 | - | Ouerdani et al. [50] | Kidney |
0.024 | 0.024 | - | Watanabe et al. [23] | Lung |
0.05 | 0.14 | 0.09 | Cardilin et al. [28] | Lung |
0.14 | 0.44 | 0.3 | Baaz et al | Lung |
0.14 | 0.4 | 0.26 | Cardilin et al. [35] | Lung |
0.22 | 0.22 | 0.28 | Cardilin et al. [37] | Lung |
0.146 | 0.146 | - | Simeoni et al. [31] | Ovarian |
0.57696a | 0.577a | 3.86 (10−5)a | Gabrielsson et al. [26] | Leukemia |
1.14 | 1.14 | - | Miao et al. [33] | Pancreatic |